Fish Oil Supplementation Alters the Plasma Lipidomic Profile and Increases Long-Chain PUFAs of Phospholipids and Triglycerides in Healthy Subjects

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Ottestad, Inger ^a,b   Hassani, Sahar ^c,d   Borge, Grethe I ^c   Kohler, Achim ^c,d   Vogt, Gjermund ^c   Hyötyläinen, Tuulia ^e   Orešič, Matej ^e   Brønner, Kirsti W ^f   Holven, Kirsten B ^b   Ulven, Stine M ^a   Myhrstad, Mari C W ^a  

^a OSLO METROPOLITAN UNIVERSITY   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c NOFIMA   (Norway)

^d NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

^e VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

^f TINE SA   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; DOCOSAHEXAENOIC ACID; FISH OIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LYSOPHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLGLYCEROL; PHOSPHATIDYLSERINE; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID; SPHINGOMYELIN; SUNFLOWER OIL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; ELECTROSPRAY; FEMALE; HUMAN; HUMAN EXPERIMENT; LIPIDOMICS; MALE; NORMAL HUMAN; QUADRUPOLE MASS SPECTROMETRY; RANDOMIZED CONTROLLED TRIAL; TIME OF FLIGHT MASS SPECTROMETRY; TRIACYLGLYCEROL BLOOD LEVEL; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

ADOLESCENT; ADULT; BODY MASS INDEX; CHROMATOGRAPHY, LIQUID; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FATTY ACIDS, UNSATURATED; FEMALE; FISH OILS; HUMANS; INTERVENTION STUDIES; LIPIDS; MALE; MASS SPECTROMETRY; MIDDLE AGED; PHOSPHOLIPIDS; PLANT OILS; REGRESSION ANALYSIS; RESEARCH DESIGN; TRIGLYCERIDES;

HELIANTHUS;

EID: 84865477877     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042550     Document Type: Article

References (42)

1. Skeaff CM, Miller J, (2009) Dietary fat and coronary heart disease: summary of evidence from prospective cohort and randomised controlled trials. Ann Nutr Metab 55: 173-201.
2. Kris-Etherton PM, Harris WS, Appel LJ, (2003) Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Arterioscler Thromb Vasc Biol 23: e20-30.
3. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (1999) Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354: 447-455.
4. Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, et al. (2007) Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 369: 1090-1098.
5. Hartweg J, Perera R, Montori V, Dinneen S, Neil HA, et al. (2008) Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus. Cochrane Database Syst Rev pp. CD003205.
6. Harris WS, (1997) n-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 65: 1645S-1654S.
7. Geleijnse JM, Giltay EJ, Grobbee DE, Donders AR, Kok FJ, (2002) Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J Hypertens 20: 1493-1499.
8. Knapp HR, (1997) Dietary fatty acids in human thrombosis and hemostasis. Am J Clin Nutr 65: 1687S-1698S.
9. Hornstra G, (2001) Influence of dietary fat type on arterial thrombosis tendency. J Nutr Health Aging 5: 160-166.
10. Christensen JH, Gustenhoff P, Korup E, Aaroe J, Toft E, et al. (1997) n-3 polyunsaturated fatty acids, heart rate variability and ventricular arrhythmias in post-AMI-patients. A clinical controlled trial. Ugeskr Laeger 159: 5525-5529.
11. Nodari S, Metra M, Milesi G, Manerba A, Cesana BM, et al. (2009) The role of n-3 PUFAs in preventing the arrhythmic risk in patients with idiopathic dilated cardiomyopathy. Cardiovasc Drugs Ther 23: 5-15.
12. Gross RW, Han X, (2011) Lipidomics at the interface of structure and function in systems biology. Chem Biol 18: 284-291.
13. Seppanen-Laakso T, Oresic M, (2009) How to study lipidomes. J Mol Endocrinol 42: 185-190.
14. Quehenberger O, Armando AM, Brown AH, Milne SB, Myers DS, et al. (2010) Lipidomics reveals a remarkable diversity of lipids in human plasma. J Lipid Res 51: 3299-3305.
15. Kontush A, Chapman MJ, (2010) Lipidomics as a tool for the study of lipoprotein metabolism. Curr Atheroscler Rep 12: 194-201.
16. Fekete K, Marosvolgyi T, Jakobik V, Decsi T, (2009) Methods of assessment of n-3 long-chain polyunsaturated fatty acid status in humans: a systematic review. Am J Clin Nutr 89: 2070S-2084S.
17. Lankinen M, Schwab U, Kolehmainen M, Paananen J, Poutanen K, et al. (2011) Whole grain products, fish and bilberries alter glucose and lipid metabolism in a randomized, controlled trial: the sysdimet study. PLoS ONE 6: e22646.
18. Lankinen M, Schwab U, Erkkila A, Seppanen-Laakso T, Hannila ML, et al. (2009) Fatty fish intake decreases lipids related to inflammation and insulin signaling-a lipidomics approach. PLoS ONE 4: e5258.
19. Harris WS, (1989) Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. J Lipid Res 30: 785-807.
20. Hodge AM, Simpson JA, Gibson RA, Sinclair AJ, Makrides M, et al. (2007) Plasma phospholipid fatty acid composition as a biomarker of habitual dietary fat intake in an ethnically diverse cohort. Nutr Metab Cardiovasc Dis 17: 415-426.
21. Schwab U, Seppanen-Laakso T, Yetukuri L, Agren J, Kolehmainen M, et al. (2008) Triacylglycerol fatty acid composition in diet-induced weight loss in subjects with abnormal glucose metabolism-the GENOBIN study. PLoS ONE 3: e2630.
22. Rhee EP, Cheng S, Larson MG, Walford GA, Lewis GD, et al. (2011) Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J Clin Invest 121: 1402-1411.
23. Ottestad I, Vogt G, Retterstol K, Myhrstad MC, Haugen JE, et al. (2011) Oxidised fish oil does not influence established markers of oxidative stress in healthy human subjects: a randomised controlled trial. Br J Nutr doi:10.1017/S0007114511005484.
24. Pluskal T, Castillo S, Villar-Briones A, Oresic M, (2010) MZmine 2: modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC Bioinformatics 11: 395.
25. Wangen LE, Kowalski BR, (1989) A multiblock partial least squares algorithm for investigating complex chemical systems. Journal of Chemometrics 3: 3-20.
26. Hassani S, Martens H, Qannari M, Hanafi M, Kohler A, (2011) Model validation and error estimation in multi-block partial least squares regression. Chemometrics and Intelligent Laboratory Systems 10.1016/j.chemolab.2011.06.001.
27. McCombie G, Browning LM, Titman CM, Song M, Shockcor J, et al. (2009) Omega-3 oil intake during weight loss in obese women results in remodelling of plasma triglyceride and fatty acids. Metabolomics 5: 363-374.
28. Block RC, Duff R, Lawrence P, Kakinami L, Brenna JT, et al. (2010) The effects of EPA, DHA, and aspirin ingestion on plasma lysophospholipids and autotaxin. Prostaglandins Leukot Essent Fatty Acids 82: 87-95.
29. Lagarde M, Bernoud N, Brossard N, Lemaitre-Delaunay D, Thies F, et al. (2001) Lysophosphatidylcholine as a preferred carrier form of docosahexaenoic acid to the brain. J Mol Neurosci 16: 201-204 discussion 215-221.
30. Hammad SM, (2011) Blood sphingolipids in homeostasis and pathobiology. Adv Exp Med Biol 721: 57-66.
31. Hammad SM, Pierce JS, Soodavar F, Smith KJ, Al Gadban MM, et al. (2010) Blood sphingolipidomics in healthy humans: impact of sample collection methodology. J Lipid Res 51: 3074-3087.
32. Pfeiffer A, Bottcher A, Orso E, Kapinsky M, Nagy P, et al. (2001) Lipopolysaccharide and ceramide docking to CD14 provokes ligand-specific receptor clustering in rafts. Eur J Immunol 31: 3153-3164.
33. de Mello VD, Lankinen M, Schwab U, Kolehmainen M, Lehto S, et al. (2009) Link between plasma ceramides, inflammation and insulin resistance: association with serum IL-6 concentration in patients with coronary heart disease. Diabetologia 52: 2612-2615.
34. Shearer GC, Savinova OV, Harris WS, (2011) Fish oil- How does it reduce plasma triglycerides? Biochim Biophys Acta doi:10.1016/j.bbalip.2011.10.011.
35. Calder PC, (2006) n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 83: 1505S-1519S.
36. Sijben JW, Calder PC, (2007) Differential immunomodulation with long-chain n-3 PUFA in health and chronic disease. Proc Nutr Soc 66: 237-259.
37. Jump DB, (2008) n-3 polyunsaturated fatty acid regulation of hepatic gene transcription. Curr Opin Lipidol 19: 242-247.
38. Tontonoz P, Spiegelman BM, (2008) Fat and beyond: the diverse biology of PPARgamma. Annu Rev Biochem 77: 289-312.
39. Kliewer SA, Sundseth SS, Jones SA, Brown PJ, Wisely GB, et al. (1997) Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc Natl Acad Sci USA 94: 4318-4323.
40. Hong C, Tontonoz P, (2008) Coordination of inflammation and metabolism by PPAR and LXR nuclear receptors. Curr Opin Genet Dev 18: 461-467.
41. Yetukuri L, Soderlund S, Koivuniemi A, Seppanen-Laakso T, Niemela PS, et al. (2010) Composition and lipid spatial distribution of HDL particles in subjects with low and high HDL-cholesterol. J Lipid Res 51: 2341-2351.
42. Yetukuri L, Huopaniemi I, Koivuniemi A, Maranghi M, Hiukka A, et al. (2011) High density lipoprotein structural changes and drug response in lipidomic profiles following the long-term fenofibrate therapy in the FIELD substudy. PLoS ONE 6: e23589.